-
Ua hōʻoia ka noiʻi ʻana o nā ʻepekema Australia e hiki i ka NMN ke hoʻoikaika i nā iwi
I ko mākou mau makahiki, lilo ko mākou mau iwi i palupalu a hiki i ka haʻihaʻi ʻana, a hiki i nā lāʻau lapaʻau o kēia manawa ke hoʻonui haʻahaʻa i ka iwi iwi.Piʻi nui kēia pilikia no ka mea ʻaʻole ʻike ʻia ke kumu kumu o ka osteoporosis (ke emi ʻana o ka iwi iwi a me ka nui).I kēia mau lā, ua hoʻopuka nā mea noiʻi Australia i ka ʻepekema ...Heluhelu hou aku -
Hoʻopau ka NMN i ka fibrosis intestinal i hoʻoulu ʻia e ka radiation ma o ka hoʻololi ʻana i ka microbiota gut
ʻO ka fibrosis intestinal i hoʻoulu ʻia e ka radiation he hoʻopiʻi maʻamau o nā mea ola lōʻihi ma hope o ka radiotherapy abdominal a pelvic.I kēia manawa, ʻaʻohe ala lapaʻau e mālama ai i ka fibrosis intestinal i hoʻoiho ʻia e ka radiation.Ua hōʻike ʻia nā haʻawina e loaʻa i ka nicotinamide mononucleotide (NMN) ka pote ...Heluhelu hou aku -
Huli Huli Huli |Hōʻike ka haʻawina ʻo Tsinghua University hiki iā NMN ke mālama i ka mumū
ʻO ka hoʻoulu ʻana o ka macrophage he mea pathogenic e alakaʻi ai i ka mumū mau i loko o ke kino, akā ʻo ka hoʻomau ʻana o ka macrophage activation hiki ke alakaʻi i ka ʻeha mau a me nā maʻi e like me ke kū ʻana o ka insulin a me nā maʻi koʻikoʻi e like me ke atherosclerosis.PGE 2 , ka mea i hoʻopaʻa i ka pane inflammatory ...Heluhelu hou aku -
Molecular Metabolism: Ka hopena therapeutic o NMN supplementation ma polycystic ovary syndrome
I nā makahiki i hala iho nei, me ka piʻi ʻana o ke ola kino ʻole a me ka piʻi ʻana o ke kaumaha o ka nohona o nā wahine, ua ʻike ʻia ka nui o ka maʻi o ka polycystic ovary syndrome (PCOS).Ua hōʻike ʻia nā haʻawina ʻē aʻe i ka maʻi o ka polycystic ovary syndrome (PCOS) i nā wahine o ka hānau keiki.Heluhelu hou aku -
Ka haʻawina hoʻomaʻamaʻa ma ke kino kanaka: Hiki i ka NMN ke hoʻemi pono i ka pae triglyceride
ʻO Triglyceride (TG) kahi ʻano momona me ka nui o nā mea i loko o ke kino kanaka.Hiki i nā ʻāpana a me nā ʻiʻo o ke kino ke hoʻohana i ka triglyceride e hāʻawi i ka ikehu, a hiki i ke ake ke hoʻohui i ka triglyceride a mālama i loko o ke ake.Inā hoʻonui ʻia ka triglyceride, ʻo ia ka mea e hōʻiliʻili nui ai ke ake f...Heluhelu hou aku -
Ua ʻae ʻo FDA i ka ibrutinib no ka mālama ʻana i ka maʻi graft-versus-host maʻi (cGVHD) i nā keiki
Ma ʻAukake 24, 2022, ua ʻae ka US Food and Drug Administration (FDA) i ka ibrutinib no ka mālama ʻana i nā maʻi pediatric i ʻoi aku ma mua o 1 makahiki me ka maʻi graft-versus-host maʻi (cGVHD) e loaʻa ana Ma hope o ka pau ʻole o ka 1- a i ʻole ka laina nui. hoʻōla ʻōnaehana .ʻO ka hōʻailona i'āponoʻia no ka ...Heluhelu hou aku -
ʻO kahi moʻolelo moʻolelo o Nicotinamide Adenine Dinucleotide (NAD) + Intermediates Nicotinamide Riboside a me Nicotinamide Mononucleotide no ka Keratinocyte Carcinoma Risk Reduction
ʻO Nicotinamide adenine dinucleotide (NAD+) kahi wahi hoʻonaʻauao noiʻi o nā ʻepekema ma ka home a ma waho.Manaʻo ka hapa nui o nā ʻepekema ʻo ke kiʻekiʻe o ka NAD + e pili kokoke ana i nā maʻi maʻi e pili ana i ka makahiki, e like me ka maʻi kanesa, ka momona, ka hypertension a me ka maʻi diabetes.ʻO ka maʻi maʻi Keratinocyte ...Heluhelu hou aku -
ʻIke hou: Hiki i ka NMN ke hoʻomaikaʻi i nā pilikia fertility ma muli o ka momona
ʻO ka oocyte ka hoʻomaka ʻana o ke ola o ke kanaka, ʻo ia ka pūnāwai hua manu ʻole a lilo i hua.Eia naʻe, e emi ana ka maikaʻi o ka oocyte i ka makahiki o nā wāhine a i ʻole nā kumu e like me ka momona, a ʻo nā oocytes haʻahaʻa ke kumu nui o ka haʻahaʻa haʻahaʻa o nā wahine momona.Eia naʻe...Heluhelu hou aku -
Hōʻike noiʻi ʻepekema |Hiki i ka Spermidine ke mālama i ka hypopigmentation
ʻO ka Hypopigmentation kahi maʻi ʻili, hōʻike nui ʻia e ka hoʻemi ʻana o ka melanin.ʻO nā hōʻailona maʻamau ka vitiligo, albinism a me ka hypopigmentation ma hope o ka mumū o ka ʻili.I kēia manawa, ʻo ka lāʻau lapaʻau nui no ka hypopigmentation ka lāʻau lapaʻau waha, akā ʻo ka lāʻau lapaʻau e hoʻoulu i ka ʻili ma ...Heluhelu hou aku -
Nūhou Nui!ʻO SyncoZymes (Shanghai) Co., Ltd. Ua hala ka palapala NMN maka mua o ka honua i ka palapala hōʻoia FDA NDI.
Ma hope o ka loiloi koʻikoʻi e ke komite ʻoihana o ka US FDA (US Food and Drug Administration) hui mana, ma Mei 17, 2022, SyncoZymes (Shanghai) Co., Ltd. ua loaʻa ʻole ka palapala hōʻoia a ka FDA (AKL): NMN raw material successfully ua hala ND...Heluhelu hou aku -
Ka holomua o ka noiʻi e pili ana i ka enzymatic synthesis o nā mea mua o Clenbuterol i ka hui pū ʻana ma waena o Norwegian University of Science and Technology a me Shangke Biomedical.
ʻO Clenbuterol, he β2-adrenergic agonist (β2-adrenergic agonist), e like me ka ephedrine (Ephedrine), hoʻohana pinepine ʻia e mālama i ka maʻi obstructive pulmonary maʻi (COPD), ua hoʻohana ʻia ʻo ia ma ke ʻano he bronchodilator e hoʻomaha i nā exacerbations o ka hānō.I ke kakahiaka 1 ...Heluhelu hou aku -
ʻO Zhejiang Shangke Biopharmaceutical Co., Ltd. Ua hala ka papahana catalysis enzyme i ka loiloi mua o ka noiʻi nui a me ka hoʻolālā hoʻomohala o Zhejiang Province
I ʻAukake 2020, ka papahana "Bio-enzyme Library Development and Green Catalytic Synthesis Application" o Zhejiang Shangke Biopharmaceutical Co., Ltd. i hala i ka loiloi mua o ka Zhejiang Provincial Key R&D Program o ka Zhejiang Provincial Department of Science and Tech...Heluhelu hou aku
